Compare AUTL & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUTL | DXYZ |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United Kingdom | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 433.8M | 447.0M |
| IPO Year | 2018 | 2024 |
| Metric | AUTL | DXYZ |
|---|---|---|
| Price | $1.38 | $34.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.33 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | N/A |
| Earning Date | 03-19-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $51,128,000.00 | N/A |
| Revenue This Year | $672.42 | N/A |
| Revenue Next Year | $84.48 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 406.67 | N/A |
| 52 Week Low | $1.11 | N/A |
| 52 Week High | $2.70 | N/A |
| Indicator | AUTL | DXYZ |
|---|---|---|
| Relative Strength Index (RSI) | 39.91 | 61.70 |
| Support Level | $1.38 | $28.84 |
| Resistance Level | $1.48 | $36.66 |
| Average True Range (ATR) | 0.10 | 2.15 |
| MACD | -0.02 | 0.38 |
| Stochastic Oscillator | 9.51 | 72.99 |
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.